AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABVC BIOPHARMA, INC. Director's Dealing 2021

Nov 15, 2021

34380_dirs_2021-11-15_23494591-d8a6-4a51-8a10-9b25f09818dd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-08-02

Reporting Person: Jiang Chang-Jen (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5949	Indirect

Footnotes

F1: Dr. Chang-Jen Jiang holds 1,343 shares of common stock in the Company through his ownership in BioFirst, 6 shares of the Company's common stock through Rgene, and the rest of 4,600 shares through direct ownership.